Live Breaking News & Updates on Larimar therapeutics

Stay informed with the latest breaking news from Larimar therapeutics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Larimar therapeutics and stay connected to the pulse of your community

Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives $18.50 Consensus Price Target from Analysts

Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) have been given an average rating of “Buy” by the six research firms that are covering the stock, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have issued ratings on the […]

California , United-states , Jamese-flynn , Leerink-partnrs , Nasdaq , Larimar-therapeutics-inc , Securities-exchange-commission , Wells-fargo-company , Citigroup , Sg-americas-securities , Tower-research-capital , Larimar-therapeutics

Head to Head Contrast: Centessa Pharmaceuticals (NASDAQ:CNTA) & Larimar Therapeutics (NASDAQ:LRMR)

Centessa Pharmaceuticals (NASDAQ:CNTA – Get Free Report) and Larimar Therapeutics (NASDAQ:LRMR – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership. Insider and Institutional Ownership 82.0% of Centessa […]

Altrincham , Trafford , United-kingdom , Pennsylvania , United-states , Bala-cynwyd , Centessa-pharmaceuticals , News-ratings-for-centessa-pharmaceuticals-daily , Larimar-therapeutics-inc , Get-free-report , Larimar-therapeutics

Contrasting Centessa Pharmaceuticals (NASDAQ:CNTA) & Larimar Therapeutics (NASDAQ:LRMR)

Contrasting Centessa Pharmaceuticals (NASDAQ:CNTA) & Larimar Therapeutics (NASDAQ:LRMR)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Altrincham , Trafford , United-kingdom , Bala-cynwyd , Pennsylvania , United-states , News-ratings-for-centessa-pharmaceuticals-daily , Centessa-pharmaceuticals , Larimar-therapeutics-inc , Get-free-report , Larimar-therapeutics

Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Consensus Rating of "Buy" from Brokerages

Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) have been given a consensus recommendation of “Buy” by the five brokerages that are covering the company, MarketBeat reports. Five investment analysts have rated the stock with a buy rating. The average 12-month target price among brokers that have updated their coverage on the stock […]

Leerink-partnrs , Jamese-flynn , Citigroup , Larimar-therapeutics-inc , Blue-owl-capital-holdings , Vanguard-group-inc , Blackrock-inc , Nasdaq , Jpmorgan-chase-co , Larimar-therapeutics , Get-free-report , Director-james

Larimar Therapeutics (NASDAQ:LRMR) Receives "Outperform" Rating from Leerink Partnrs

Leerink Partnrs reiterated their outperform rating on shares of Larimar Therapeutics (NASDAQ:LRMR – Free Report) in a research report released on Wednesday, Zacks.com reports. Leerink Partnrs also issued estimates for Larimar Therapeutics’ FY2026 earnings at ($2.65) EPS, FY2027 earnings at ($2.41) EPS and FY2028 earnings at ($1.75) EPS. A number of other research analysts also […]

California , United-states , Leerink-partnrs , Jamese-flynn , Larimar-therapeutics-inc , Citigroup , Securities-exchange-commission , Wells-fargo-company , Sg-americas-securities , Tower-research-capital , Larimar-therapeutics , Free-report

Larimar Therapeutics (NASDAQ:LRMR) Trading Down 4.8%

Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report)’s stock price dropped 4.8% during mid-day trading on Tuesday . The stock traded as low as $11.76 and last traded at $11.80. Approximately 33,993 shares changed hands during trading, a decline of 95% from the average daily volume of 625,641 shares. The stock had previously closed at […]

Jamese-flynn , Nasdaq , Citigroup , Larimar-therapeutics-inc , Blue-owl-capital-holdings , Blackrock-inc , Vanguard-group-inc , Larimar-therapeutics , Get-free-report , Therapeutics-trading-down , Director-james

Over $37M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying - Agree Realty (NYSE:ADC), Alteryx (NYSE:AYX)

Although U.S. stocks closed lower on Friday, there were a few notable insider trades.

Hawthorn-bancshares , Douglas-todd-eden , Alteryx-inc , Realty-corporation , Hawthorn-bancshares-inc , Larimar-therapeutics-inc , Hawthorn-bancshares-does , Dean-stoecker , Databricks-data-intelligence , Alteryx-does , Larimar-therapeutics , Deerfield-partners

Larimar Therapeutics (NASDAQ:LRMR) Stock Price Up 7%

Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) rose 7% during trading on Thursday . The stock traded as high as $13.17 and last traded at $12.80. Approximately 263,608 shares traded hands during trading, a decline of 49% from the average daily volume of 520,626 shares. The stock had previously closed at $11.96. […]

California , United-states , American , Jamese-flynn , Citigroup , American-international-group-inc , Nasdaq , Wells-fargo-company , Larimar-therapeutics-inc , Securities-exchange-commission , Larimar-therapeutics-company-profile

Larimar Therapeutics (NASDAQ:LRMR) Trading 7% Higher

Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report)’s stock price was up 7% on Thursday . The company traded as high as $13.17 and last traded at $12.80. Approximately 263,608 shares changed hands during trading, a decline of 49% from the average daily volume of 520,626 shares. The stock had previously closed at $11.96. Analyst […]

United-states , California , American , Jamese-flynn , Nasdaq , Wells-fargo-company , Larimar-therapeutics-inc , Tower-research-capital , Citigroup , American-international-group-inc , Larimar-therapeutics

Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Boston , Massachusetts , United-states , Edgewood , New-york , Michael-celano , Joyce-allaire , Larimar-therapeutics-inc , Syndicate-department , Company-contact , Nasdaq , Exchange-commission